India: Food, Drugs, Healthcare, Life Sciences

Assume your doctor prescribes a drug to you. The brand-name version costs $300 a month. Another generic drug on the other hand will cost $30. As most people would, you would also purchase the cheaper one. That generic cheaper bottle exists as a result of a delicate legal balancing act, an act that the U.S. Supreme Court is now reconsidering in a case that could change pharmaceutical competition for decades.

The Food Safety and Standards Authority of India has proposed amendments to packaging regulations that would mandate pan masala manufacturers to abandon plastic-based packaging in favor of paper, cellulose, tin, or glass materials. This regulatory intervention harmonizes food safety standards with environmental protection mandates by incorporating provisions from the Plastic Waste Management Rules, 2016, creating a comprehensive framework that addresses both public health and sustainability concerns. The dr

The present public interest litigation (PIL) is in the Supreme Court of India due to the promotion of stem cell “treatment” for Autism Spectrum Disorder (ASD).